WuXi Biologics (Cayman) Inc.
2269
Ранг среди акций
#991
Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman)... Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman) Inc. delivers a comprehensive, integrated suite of services spanning the entire biologics lifecycle, from initial discovery through development to large-scale manufacturing. The company's operations have a global footprint, serving clients across the People's Republic of China, North America, Europe, and other international regions. Its diversified offerings also include specialized consultation in biopharmaceutical technology, international sales contracting, the development and deployment of advanced testing methodologies, and robust marketing and sales support. Furthermore, WuXi Biologics is involved in providing dedicated biologics clinical and manufacturing services, the production and distribution of various medical products, contract development and manufacturing (CDMO) for vaccines and associated businesses, and acting as a supplier of key materials. The firm maintains strategic partnerships with notable entities such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc.
Цена акции
$5.74
Рыночная капитализация
$23.64B
Изменение (1 день)
-8.79%
Изменение (1 год)
24.58%
Страна
CN
Торговля WuXi Biologics (Cayman) Inc. (2269)
Категория
Healthcare
Коэффициент P/B для WuXi Biologics (Cayman) Inc. (2269)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций WuXi Biologics (Cayman) Inc., текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для WuXi Biologics (Cayman) Inc. с 2014 по 2026
Коэффициент P/B в конце каждого года
| Год | P/B | Изменить |
|---|---|---|
| 2025 | 2.49 | 54.96% |
| 2024 | 1.61 | -40.03% |
| 2023 | 2.68 | -57.33% |
| 2022 | 6.29 | -38.77% |
| 2021 | 10.28 | -41.50% |
| 2020 | 17.56 | 91.24% |
| 2019 | 9.18 | 26.97% |
| 2018 | 7.23 | -26.16% |
| 2017 | 9.80 | -90.76% |
| 2016 | 106.02 | -42.27% |
| 2015 | 183.65 | 166.79% |
| 2014 | 68.84 | 0.00% |
Коэффициент P/B для аналогичных компаний или конкурентов
| Компания | P/B | Разница P/B | Страна |
|---|---|---|---|
| 6.251 | - |
US
|
|
| 13.2547 | - |
US
|
|
| 4.208 | - |
AU
|
|
| 6.1824 | - |
NL
|
|
| - | - |
CH
|
